Thursday, October 15, 2026

Operations, Industry and Regulatory Ecosystem | GOVIS 2027

Bridging Ophthalmic Innovation, Quality, Compliance and Patient Access

Scientific breakthroughs can transform eye care, but bringing new therapies, devices, and technologies into clinical practice requires careful planning, regulatory compliance, quality management, and collaboration across the healthcare ecosystem.

The Global Ophthalmology & Vision Science Congress (GOVIS 2027) highlights Operations, Industry and Regulatory Ecosystem as a scientific topic focused on the practical processes that help ophthalmic innovations progress from development to real-world use.

Join the congress on June 14–16, 2027, in Rome, Italy, or online to exchange knowledge with professionals working across ophthalmology, research, industry, regulatory affairs, and healthcare delivery.

Key Areas of Focus

  • Clinical trial operations: Study design, site management, clinical data quality, and research coordination.
  • Regulatory affairs: Submissions and compliance pathways involving agencies such as the FDA, EMA, and PMDA.
  • Quality and manufacturing: GMP, GLP, GCP, quality systems, design controls, and supply-chain readiness.
  • Medical device compliance: MDR/IVDR requirements, traceability, labeling, and risk management.
  • Safety monitoring: Pharmacovigilance, complaint handling, and post-market surveillance.
  • Industry collaboration: Partnerships among CROs, startups, academic institutions, hospitals, and manufacturers.
  • Commercialization and sustainability: Market access, reimbursement, intellectual property, investment, and environmentally responsible practices.

From Research to Real-World Impact

Developing a promising ophthalmic therapy or device is only one step toward improving patient care. Successful implementation also requires reliable manufacturing, appropriate testing, qualified suppliers, documented processes, and effective risk management.

Cross-functional collaboration helps connect research and development with clinical evidence, regulatory requirements, quality assurance, and commercial planning. Strong documentation and data integrity also support inspection readiness and consistent product performance.

Quality, Compliance and Patient Safety

Quality systems and regulatory frameworks help ensure that ophthalmic products are developed, evaluated, manufactured, and monitored responsibly. Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and appropriate laboratory quality standards are important components of this process.

Post-market surveillance and pharmacovigilance provide continuing insight into product safety and performance after products enter clinical use. Effective complaint handling, corrective and preventive actions, and transparent reporting help organizations identify risks and improve their systems.

Market Access and Sustainable Innovation

Innovation delivers greater value when safe and effective products can reach the patients who need them. Health-economic evaluations, reimbursement strategies, real-world evidence, and payer-value frameworks can help connect clinical benefits with healthcare decision-making.

Technology transfer, intellectual-property management, startup investment, and partnerships can also support the development and adoption of new ophthalmic solutions. Meanwhile, sustainable manufacturing, responsible resource use, and eco-friendly clinical practices can help reduce the environmental impact of eye care.

Join GOVIS 2027

GOVIS 2027 offers an opportunity for clinical investigators, regulatory and quality professionals, industry leaders, researchers, entrepreneurs, and healthcare partners to exchange perspectives on strengthening the ophthalmic innovation ecosystem.

Explore the scientific topic and join the global conversation on advancing safe, compliant, accessible, and sustainable eye-care innovation.

🌐 Official Website: https://globalophthalmologycongress.com/
📝 Abstract Submission: https://globalophthalmologycongress.com/abstract-submission
📚 Scientific Topics: https://globalophthalmologycongress.com/program/scientific-topics/operations-industry-and-regulatory-ecosystem
🎟️ Registration: https://globalophthalmologycongress.com/register
📩 Contact: https://globalophthalmologycongress.com/contact

Conference Dates: June 14–16, 2027
Venue: Rome, Italy and Online

#GOVIS2027 #Ophthalmology #RegulatoryAffairs #ClinicalResearch #ClinicalTrials #MedicalDevices #QualityAssurance #Pharmacovigilance #HealthcareInnovation #VisionScience #SustainableHealthcare

No comments:

Post a Comment

One Discovery Can Change the Future of Vision | GOVIS 2027

What if one research discovery could transform the way we diagnose, treat, or prevent eye diseases? The future of ophthalmology is being sha...